NewAmsterdam Pharma Company NV

10/28/2026 | Press release | Archived content

Plasma p-tau217 Above and Below Validated Alzheimer Cutoffs in Cardiovascular Disease: Between-Range vs Within-Range Determinants in BROADWAY

NewAmsterdam Pharma Company NV published this content on October 28, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 30, 2026 at 13:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]